@article {10.3844/ajidsp.2013.117.129,
article_type = {journal},
title = {In Silico and in Vitro Studies: Tryparedoxin Peroxidase Inhibitor Activity of Methotrexate for Antileishmanial Activity},
author = {Gundampati, Ravi Kumar and Sahu, Shraddha and Srivastava, Avinash Kumar and Chandrasekaran, Sambamurthy and Vuddanda, Parameswara Rao and Pandey, Rajesh Kumar and Maurya, Radheshyam and Singh, Sanjay and Jagannadham, Medicherla V.},
volume = {9},
number = {4},
year = {2013},
month = {Nov},
pages = {117-129},
doi = {10.3844/ajidsp.2013.117.129},
url = {https://thescipub.com/abstract/ajidsp.2013.117.129},
abstract = {In order to understand the mechanism of molecular interactions at the active site of Tryparedoxin Peroxidase (Try P), homology modeling and docking studies were performed. We generated a Three-Dimensional (3D) model of target protein based on the Crystal structure of Leishmania Major Try PI (PDB ID: 3TUE) using modeler software. Docking analysis was carried out to study the effects of methotrexate on Tryparedoxin Peroxidase (Try P). Inhibition of the Tryparedoxin peroxidase interaction has become a new therapeutic strategy in treating leishmaniasis. Docking analysis was carried out to study the effects of methotrexate on Tryparedoxin Peroxidase (TryP). Tryparedoxin peroxidase of Trypanosomatidae family functions as antioxidant through their peroxidase and peroxynitrite reductase activities. The theoretical docking study, conducted on a sample previously reported for anti-cancer properties of Methotrexate at the binding site of 3D models of Tryparedoxin Peroxidase of Leishmania braziliensis (L. braziliensis Try P) examine interaction energy. Our studies indicate that Methotrexate displays potent activity against Try P with lowest binding energy and RMSD values to be -14.5879 Kcal/Mol and 2.0 A. The results of the present study clearly demonstrated the Tryparedoxin Peroxidase inhibitory activity by methotrexate in in silico docking analysis and in vitro assay which contributes towards understanding the mechanism of antileishmanial activity.},
journal = {American Journal of Infectious Diseases},
publisher = {Science Publications}
}